Michael T. Tetzlaff

1. B cells and tertiary lymphoid structures promote immunotherapy response
   2020/01/15 by Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao +67 · 34 citations
   Medicine · Immunology and Microbiology · #Cancer Immunotherapy and Biomarkers #Immune Cell Function and Interaction #CAR-T cell therapy research
2. Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma
   2018/08/20 by Anita G. Seto, Xuan Beatty, Joshua M. Lynch +5 · 28 citations
   Immunology and Microbiology · Medicine · Materials Science · #T-cell and Retrovirus Studies #Cutaneous lymphoproliferative disorders research #Silk-based biomaterials and applications
3. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
   2025/07/10 by Elizabeth M. Burton, Denái R. Milton, Michael T. Tetzlaff +25 · 11 citations
   Medicine · #Cancer Immunotherapy and Biomarkers #Cutaneous Melanoma Detection and Management #CAR-T cell therapy research